![]() ![]() However, after nearly 25 years of extensive efforts toward a better understanding of this disorder, current knowledge remains limited. Since its first description in Japan in 1990, 1 takotsubo (stress) cardiomyopathy has gained worldwide recognition. (Funded by the Mach-Gaensslen Foundation and others number, NCT01947621.) Introduction This condition represents an acute heart failure syndrome with substantial morbidity and mortality. Patients with takotsubo cardiomyopathy had a higher prevalence of neurologic or psychiatric disorders than did those with an acute coronary syndrome. During long-term follow-up, the rate of major adverse cardiac and cerebrovascular events was 9.9% per patient-year, and the rate of death was 5.6% per patient-year. Physical triggers, acute neurologic or psychiatric diseases, high troponin levels, and a low ejection fraction on admission were independent predictors for in-hospital complications. Rates of severe in-hospital complications including shock and death were similar in the two groups (P=0.93). 25.7%) and the mean left ventricular ejection fraction was markedly lower (40.7☑1.2% vs. Among patients with takotsubo cardiomyopathy, as compared with an acute coronary syndrome, rates of neurologic or psychiatric disorders were higher (55.8% vs. 36.0%), and 28.5% of patients had no evident trigger. Emotional triggers were not as common as physical triggers (27.7% vs. Of 1750 patients with takotsubo cardiomyopathy, 89.8% were women (mean age, 66.8 years). Patients were compared with age- and sex-matched patients who had an acute coronary syndrome. The International Takotsubo Registry, a consortium of 26 centers in Europe and the United States, was established to investigate clinical features, prognostic predictors, and outcome of takotsubo cardiomyopathy. The natural history, management, and outcome of takotsubo (stress) cardiomyopathy are incompletely understood. Original Article Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy List of authors. The most trusted, influential source of new medical knowledge and clinical best practices in the world. #TYPE TO LEARN JR.3 LICENSE#Information and tools for librarians about site license offerings. Valuable tools for building a rewarding career in health care. The authorized source of trusted medical research and education for the Chinese-language medical community. The most advanced way to teach, practice, and assess clinical reasoning skills. Information, resources, and support needed to approach rotations - and life as a resident. The most effective and engaging way for clinicians to learn, improve their practice, and prepare for board exams. NEW! Peer-reviewed journal featuring in-depth articles to accelerate the transformation of health care delivery.Ĭoncise summaries and expert physician commentary that busy clinicians need to enhance patient care. #TYPE TO LEARN JR.3 TRIAL#NEW! A digital journal for innovative original research and fresh, bold ideas in clinical trial design and clinical decision-making. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |